Recurrent Adult Immunoblastic Large Cell Lymphoma Completed Phase 1 / 2 Trials for DB01181 (Ifosfamide)

IndicationStatusPhase
DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00601718Vorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell LymphomaTreatment